期刊文献+

抗AML特异性T细胞的诱导、扩增及功能研究

Induction,proliferation and functional study of specific anti-acute myeloid leukemia(AML) T cells
下载PDF
导出
摘要 目的:体外培养抗急性髓性白血病(AML)细胞的特异性T细胞,并研究其生物学特性和功能。方法:取12例AML患者的外周血或骨髓,分离单个核细胞(MNCs)后接种于96孔板,加入组合细胞因子,诱导AML细胞来源的树突细胞(DC)生成,培养过程中用倒置显微镜进行形态学观察,并在7天后用流式细胞术检测免疫学表型。培养第7天时将组合细胞因子培养液换为高IL-2因子培养液,促进抗AML细胞的特异性T细胞生长,培养4~5周后测定T细胞表型,并采用乳酸脱氢酶(LDH)释放法进行T细胞杀伤活性测定。结果:AML细胞经组合细胞因子诱导后,大部分细胞呈现树突状细胞的典型形态,而且CD80、CD86和HLA-DR较培养前明显上调(P<0.01);高IL-2因子培养液培养4~5周后,82.5%的培养孔内CD3+ T细胞占孔内细胞总数99%以上;LDH释放法进行T细胞杀伤试验表明培养出的T细胞对自体AML有较强的杀伤作用,而对异体AML细胞杀伤力弱。结论:在体外可以成功诱导出抗AML细胞的特异性T细胞,且培养出的T细胞对自体AML细胞有特异性杀伤作用。 Objective:To develop specific anti-AML T cells in vitro, and to study their biological characteristics and functions. Methotis: Peripheral blood or bone marrow mononuclear cells (MNCs) were isolated from 12 patients with AML, and co-cultured with cytokine combinations in 96 well plates to be induced into dendritic cells (DCs). Cell morphology was observed under an inverted microscope during the first week and immunophenotype was detected by flow cytometry at day 7. Cytokine combination was replaced with high dose IL-2 at day 7 to promote specific anti-AML T cells. T cell phenotype was detected after 4 to 5 weeks. Lactate dehydrogenase (LDH) release assay was used to determine T cell killing activity. Results: After being cultured with cytokine combinations, the typical dendritic appearance with delicate membrane projections was observed. CD80, CD86 and HLA-DR markers were significantly upregulated( P 〈 0.01 ). 82.5 % of the wells contained more than 99% of CD3^+T cells. LDH release showed that these T cells caused specific lysis of autologous AML cells but not allogeneic AML cells. Conclusion: Specific anti-AML T cells can be deduced in vitro, and these T cells can kill autologous AML cells specifically.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第10期912-915,共4页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(30650004)
关键词 急性髓性白血病 树突细胞 T淋巴细胞 免疫治疗 Aute myeloid leukemia (AML) Dendritic cell (DC) T lymphocyte Immunotherapy
  • 相关文献

参考文献15

  • 1Guirm B A, Gilkes A F, Woodward E et al. Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia[J]. Biochem Biophys Res Commun,2005 ;333(3):703-713.
  • 2Scheibenbogen C, Letsch A, Thiel E et al. CD8 T-cell responses to Wilms tumor gene product WTI and proteinase 3 in patients with acute myeloid leukemia[J]. Blood, 2002; 100(6) :2132-2137.
  • 3陈少华,李扬秋,杨力建,黄梅娟,韩素芳,罗更新,陈盛亭.AML-M2a诱导TCR VβT细胞的克隆性增殖和细胞毒作用[J].中国肿瘤生物治疗杂志,2004,11(3):195-199. 被引量:1
  • 4Mayordomo J, Zorina T, Storkus Wet al. Bone marrow derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity[ J]. Nature Med, 1995 ; 1 (12) : 1297-1302.
  • 5Lee J J, Kook H, Park M S et al. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myelold leukemia relapse after autologous peripheral blood stem cell transplantation[J] .J Clin Apher,2004; 19(2):66-70.
  • 6Harrison B D, Adams J A, Briggs Met al. Stimulation of autologous prolif- erative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia[ J]. Blood, 2001;97 (9): 2764-2771.
  • 7Choudhury B A, Liang J C, Thomas E K et al. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antilcukemie T-ecll responses[J]. Blood, 1999;93(3) :780-786.
  • 8Charbonnier A, Gaugler B, Sainty D et al. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias [ J ]. Eur J Immunol, 1999 ; 29 (8) : 2567-2578.
  • 9Zhong R K, Rassenti L Z, Kipps T Jet al. Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia[ J ]. Biol Blood Marrow Transplant, 2002 ; 8 ( 10 ) : 557-568.
  • 10Zhong R K, Lane T A, Ball E D et al. C33A-4 Blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system [ J ]. Cytotherapy, 2006;8(1) :3-12.

二级参考文献17

  • 1Lu PH, Negrin BS. A novel population of expanded human CD3^+ CD56^+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency [ J ]. J Immunol, 1994, 153(4): 1687-1696.
  • 2Schmidt-Wolf GD, Negrin RS, Schmidt - Wolf IG. Activated T cells and cytokine-induced CD3^+ CD56^+ killer cells[ J ]. Ann Hematol, 1997, 74(2) : 51-56.
  • 3Hoyle C, Bangs CD, Negrin BS, et al. Expansion of Philadelphia chromosome - negative CD3^+ CD56^+ cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice [ J ]. Blood, 1998, 92(9) : 3318-3327.
  • 4Schmidt-Wolf IG, Finke S, Huhn D, et al. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer,colorectal cancer and lymphoma[J]. Br J Cancer, 1999, 81(6) :1009-1016.
  • 5Margolin KA, Negrin BS, Forman SJ, et al. Cellular immunotherapy and autologous transplantation for hematologic malignancy[J].Immunol Rev, 1997, 157: 231-240.
  • 6Kayagaki N, Yamaguchi N, Nakayama M, et al. Involvement of TNF-related apoptosis inducing ligand in human CD4^+ T cell-mediated cytotoxicity[ J]. J Immunol, 1999, 162 : 2639-2647.
  • 7Jeremias I, Herr I, Boehler T, et al. TRAIL-APO-2-1igand-induced apoptosis in human T cells[J]. Eur J Immunol, 1998, 28:143-152.
  • 8Mutis T, Schrama E, van Luxemburg-Heijs SA, et al. HLA class Ⅱ restricted T cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34 + early progenitor cells [ J ].Blood, 1997, 90(3): 1083-1090.
  • 9Rezvany MR, Jeddi-Tehrani M, Wigzell H, et al. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia [ J ]. Blood, 2003, 101 ( 3 ):1063-1070.
  • 10Hayashi K, Yonamine K, Masuko-HongoK, et al. Clonal expansion of T cells that are specific for autologous ovarian tumor amongtumor infiltrating T cells in humans[J]. Gynecol Oncol, 1999,74(1): 86-92.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部